Abstract
Lung tissue is involved in the synthesis and/or metabolism of many vasoactive substances such as histamine, serotonin, dopamine, norepinephrine, bradikinin, angiotensin II and prostaglandins (1).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Y. Bakhle, J.R. Vane, Metabolic function of the lungs. In: Marcel Dekker, Inc., New York and Basel, 1977.
S.M.M. Karim, P.G. Adaikan, S.R. Cottegoda, Prostaglandins and human respiratory smooth muscle: structure-activity relationship. In: Advances in prostaglandins and thromboxane research, Vol. 7, edited by Samuelsson B., Romvell P.W. and Paoletti R., Raven Press, New York, p. 969, 1980.
P.I. Kadowitz, E.W. Spannhake, J.L. Levin, A.L. Hyman, Differential actions of prostaglandins and the pulmonary vascular bed. In: Advances in prostaglandins and thromboxane research, Vol. 7, edited by Samuelsson B., Romvell P.W. and Paoletti R., Raven Press, New York, p. 731, 1980.
A.P. Smith, Advances in prostaglandin research. Practical applications of prostaglandins and their synthesis inhibitors, edited by S.M.M. Karim, M.T.P. Press Ltd, Lancaster, 83, 1976.
P.J. Kadowitz, A.L. Hyman, Vasoconstrictor effects of thromboxane B2 on the canine and feline pulmonary bed. In press.
R.J. Gryglewski, R. Korbutt, A. Ocetkiewicz, Generation of prostacyclin by the lungs in vivo and its release into the arterial circulation. Nature 273:765 (1978).
R.J. Gryglewski, Is the lung an endocrine organ that secretes prostacyclin. In: Prostacyclin, edited by J.R. Vane and S. Bergstrom, Raven Press, New York, p.275, 1979.
A. Musca, C. Cordova, F. Violi, A. Perrone, C. Alessandri, F. Pavone, F. Balsano, Fibrin polymerization behaviour in patients with chronic respiratory failure. In: (Abstract), VIII European Congress of Cardiology, Paris, June 22–26, 1980.
A. Paunesco-Podeanu, C. Bratu, T. Tarachiu, M. Cotsecu, V. Bratu, A. Bucur, Les thromboses pulmonaires qui compliquent l’insuffisance respiratoire et le coeur pulmonaire chronique. Med. Int. (Buc.) 25:473 (1973).
F. Balsano, C. Cordova, A. Musca, A. Perrone, F. Violi, Metabolismo polmonare ed emocoagulazione in fisiologia, patologia e clinica. Clin. Ter. 80:513 (1977).
P. Steel, H.R. Ellis, S. Weily, E. Genton, Platelet survival time in patients with hypoxemia and pulmonary hypertension. Circulation 55:660 (1977).
R. Breda, B. Bizzi, R. Landolfi, Ruolo del polmone nell’emocoagulazione. Clin. Ter. 94 (Suppl. 1), 1, 41 (1980).
E. Tremoli, L. Bertoli, P. Maderna, F. Conti, R. Marlini, O. Mantero, Platelet antiaggregating therapy in chronic obstructive lung disease. Clin. Resp. Physiol. 16:84 (1980).
C. Cordova, A. Musca, F. Violi, G.C. De Mattia, A. Perrone, C. Alessandri, F. Balsano, Plasma beta-thromboglobulin levels in patients with chronic respiratory failure. In: Abstracts. VIII European Congress of Cardiology, Paris, June 22–26, 1980.
D.A. Rickaby, C.A. Dawson, M.B. Maron, Pulmonary inactivation of serotonin and site of serotonin pulmonary vasoconstriction. J. Appl. Physiol. 48:606 (1980).
J. Svensson, T. Strandberg, T. Tuveno, M. Hamberg, Thromboxane A2: effects on airway and vascular smooth muscle. Prostaglandins 14:426 (1977).
J.D. Dusting, S. Moncada, J. Vane, Prostaglandins, their intermediates and precursors: cardiovascular actions and regulatory role in normal and abnormal circulatory system. Progr. Cardiovasc. Dis. 21:405 (1979).
J.C. Frölich M. Ogletree, B.A. Peskar, K.L. Brigham, Pulmonary hypertension correlated to pulmonary thromboxane synthesis. In: Advances in prostaglandin and thromboxane research, Vol. 7, edited by Samuelsson P., Romwell P.W. and Paoletti R., Raven Press, New York, p. 745, 1980.
K. Radegran, S.E. Bergentz, D.H. Lewis, U. Ljungquist, P. Olsson, Pulmonary effects of induced platelet aggregation. Intravascular obstruction or vasoconstriction? Scand. J. Clin. Lab. Invest. 28:423 (1971).
G. Bo, J. Hognestad, Effects on the pulmonary circulation of suddenly induced intravascular aggregation of blood platelets. Acta Physiol. Scand. 85:523 (1972).
S. Moncada, R. Corbutt, Dipyridamole and other phosphodiesterase inhibitors act as antithrombotic agents by potentiating endogenous prostacyclin. Lancet 1:1268 (1978).
K.A. Jorgensen, J. Dyeberg, E. Stoffersen, Prostacyclin (PGI2) and the effect of phosphodiesterase inhibitors on platelet aggregation. Pharm. Res. Commun. 11:605 (1979).
K.E. Blass, H.U. Block, W. Förster, K. Ponicke, Dipyridamole, a potent stimulator of prostacyclin (PGI2) biosynthesis. Br. J. Pharmacol. 68:71 (1980).
G.G. Neri Serneri, G. Masotti, L. Poggesi, G. Galanti, S. Castellani, Dipyridamole stimulates prostacyclin biosynthesis in man and in vitro. In: 6th International Congress on Thrombosis, Montecarlo, October 23–25, 1980.
G.G. Neri Serneri, G. Masotti, R. Abbate, S. Fabula, L. Poggesi, G.F. Gensini, G. Galanti, R. Laureano, Enhanced prostacyclin production and decreased thromboxane formation by dipyridamole. In: Florence International Meeting on Myocardial Infarction, Experta Medica, Vol. I, p.489, 1979.
G. Masotti, G. Galanti, L. Poggesi, R. Abbate, G.G. Neri Serneri, Differential inhibition of PGI2 production and platelet aggregation by aspirin in humans. In: 5th International Congress on Thromboembolism, Bologna May 29-June 2 (Abstract) p.46, 1978.
G. Masotti, R. Abbate, G. Galanti, L. Poggesi, G.G. Neri Serneri, Are conventional doses of acetylsalicyclic acid advisable in prevention of thrombosis? In: Florence International Meetings on Myocardial Infarction, Experta Medica, Vol. I, p.489, 1979.
C.A. Ludlam, B. Moores, A. Boctona, D.S. Pepper, J.D. Cash, The release of a human platelet specific protein measured by radioimmunoassay. Thromb. Res. 6:543 (1975).
R.J. Lewy, J.B. Smith, M.J. Silver, J. Saia, P. Walinsky, L. Weiner, Detection of thromboxane B2 in peripheral blood of patients with Prinzmetal angina. Prostaglandins Med. 42:425 (1979).
J.A. Salmon, A radioimmunoassay for 6-keto PGF1α. Prostaglandins 3:383 (1978).
J.A. Nadel, J.H. Comore, Acute effect of inhalation of cigarette smoke on airway conductance. J. Appl. Physiol. 16:713 (1961).
G.M. Starling, Mechanism of bronchoconstriction caused by cigarette smoking. Br. Med. J. 3:275 (1967).
J.M. Miller, B.J. Sproule, Acute effects of inhalation of cigarette smoke on mechanical properties of the lungs. Am. Rev. Resp. Dis. 94:721 (1966).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Plenum Press, New York
About this chapter
Cite this chapter
Novo, S. et al. (1984). Platelet Activity in Relation to Smoke and Exercise in Patients with Chronic Obstructive Lung Disease: Effects of Platelet Antiaggregating Drugs. In: Strano, A. (eds) Thrombosis and Cardiovascular Disease. Advances in Experimental Medicine and Biology, vol 164. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-8616-2_34
Download citation
DOI: https://doi.org/10.1007/978-1-4684-8616-2_34
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-8618-6
Online ISBN: 978-1-4684-8616-2
eBook Packages: Springer Book Archive